Following a recent extension of azelastine/fluticasone 125/50 for use in children aged 6 and over for allergic rhinitis and rhino-conjunctivitis, we’ve enclosed a Product Review examining the trial evidence of its use in this population. Independent commentary has been provided by rhinologist Dr Raewyn Campbell, Clinical Associate Professor at Macquarie University in Sydney.
Please login below to download this issue (PDF)